Pricing Log in Create free account

Ocular Therapeutix, Inc. (OCUL) vs Tyra Biosciences, Inc. (TYRA)

Ocular Therapeutix, Inc. and Tyra Biosciences, Inc. are both Biotechnology companies. Ocular Therapeutix, Inc. and Tyra Biosciences, Inc. are of similar size ($1.4B and $1.4B). Tyra Biosciences, Inc. has the higher net margin (0.00% vs −579.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Tyra Biosciences, Inc. leads on 10 and Ocular Therapeutix, Inc. on 3.

Valuation

Metric OCUL TYRA Biotechnology median
P/E n/m n/m 10.60
P/S 28.61 n/m 9.40
P/B 2.86 3.94 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 18.51 n/m 9.02
Earnings yield (21.45%) (11.38%) (32.88%)
Free cash flow yield (17.13%) (7.90%) (23.13%)

Profitability

Metric OCUL TYRA Biotechnology median
Gross margin 87.11% 0.00% 68.51%
Operating margin (603.04%) 0.00% 0.00%
Net margin (579.10%) 0.00% 0.00%
Free cash flow margin (490.07%) 0.00% 0.00%
Return on equity (72.99%) (45.31%) (51.96%)
Return on assets (53.70%) (42.15%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OCUL TYRA Biotechnology median
Revenue growth (TTM) (8.14%) — 6.76%
EPS growth (last fiscal year) (16.39%) (33.11%) 29.88%
Revenue growth, 5-year CAGR 24.45% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OCUL TYRA Biotechnology median
Debt to equity 0.14 0.00 0.00
Current ratio 13.11 14.91 4.97
Net debt to EBITDA 2.51 1.94 1.01

Dividend

Metric OCUL TYRA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric OCUL TYRA Biotechnology median
Market cap 1.41b 1.44b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack